Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients
Increased adiposity is a risk factor for multiple sclerosis (MS) and is associated with increased disability scores. Adipokines may mediate the effects of adiposity on MS disease course. The objective of this study is to examine the association between the adipokines (leptin and fatty acid binding p...
Saved in:
| Published in: | Multiple sclerosis Vol. 25; no. 3; p. 344 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
01.03.2019
|
| Subjects: | |
| ISSN: | 1477-0970, 1477-0970 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Increased adiposity is a risk factor for multiple sclerosis (MS) and is associated with increased disability scores. Adipokines may mediate the effects of adiposity on MS disease course.
The objective of this study is to examine the association between the adipokines (leptin and fatty acid binding protein-4, FABP4) and clinical course in individuals with MS.
Subjects (18-65 years) with relapsing-remitting MS or clinically isolated syndrome and <10 year disease duration were selected from a longitudinal clinical study. Cross-sectional and longitudinal models assessed the relationship between two adipokines (leptin and FABP4) and disease severity in women and men, adjusting for age, disease duration and disease type, Vitamin D level, testosterone level, and as well by body mass index (BMI).
Mean age of subjects ( N = 163, 56% women) was 39.3 years. Higher FABP4 levels were associated with higher Expanded Disability Status Scale (EDSS) scores in women in both univariate and multivariate analyses (odds ratio: 1.30; p = 0.005). In men, higher FABP4 level was significantly associated with change in EDSS over time (estimate: 0.0062; p = 0.035). We found no association of FABP4 levels with time to next relapse or a measure of processing speed.
FABP4 levels may be associated with increased disability in both men and women with MS independent of effects of BMI and other hormones. Future studies should expand these analyses and further explore downstream mechanisms of adiposity-related effects in MS. |
|---|---|
| AbstractList | Increased adiposity is a risk factor for multiple sclerosis (MS) and is associated with increased disability scores. Adipokines may mediate the effects of adiposity on MS disease course.
The objective of this study is to examine the association between the adipokines (leptin and fatty acid binding protein-4, FABP4) and clinical course in individuals with MS.
Subjects (18-65 years) with relapsing-remitting MS or clinically isolated syndrome and <10 year disease duration were selected from a longitudinal clinical study. Cross-sectional and longitudinal models assessed the relationship between two adipokines (leptin and FABP4) and disease severity in women and men, adjusting for age, disease duration and disease type, Vitamin D level, testosterone level, and as well by body mass index (BMI).
Mean age of subjects ( N = 163, 56% women) was 39.3 years. Higher FABP4 levels were associated with higher Expanded Disability Status Scale (EDSS) scores in women in both univariate and multivariate analyses (odds ratio: 1.30; p = 0.005). In men, higher FABP4 level was significantly associated with change in EDSS over time (estimate: 0.0062; p = 0.035). We found no association of FABP4 levels with time to next relapse or a measure of processing speed.
FABP4 levels may be associated with increased disability in both men and women with MS independent of effects of BMI and other hormones. Future studies should expand these analyses and further explore downstream mechanisms of adiposity-related effects in MS. Increased adiposity is a risk factor for multiple sclerosis (MS) and is associated with increased disability scores. Adipokines may mediate the effects of adiposity on MS disease course.BACKGROUNDIncreased adiposity is a risk factor for multiple sclerosis (MS) and is associated with increased disability scores. Adipokines may mediate the effects of adiposity on MS disease course.The objective of this study is to examine the association between the adipokines (leptin and fatty acid binding protein-4, FABP4) and clinical course in individuals with MS.OBJECTIVEThe objective of this study is to examine the association between the adipokines (leptin and fatty acid binding protein-4, FABP4) and clinical course in individuals with MS.Subjects (18-65 years) with relapsing-remitting MS or clinically isolated syndrome and <10 year disease duration were selected from a longitudinal clinical study. Cross-sectional and longitudinal models assessed the relationship between two adipokines (leptin and FABP4) and disease severity in women and men, adjusting for age, disease duration and disease type, Vitamin D level, testosterone level, and as well by body mass index (BMI).METHODSSubjects (18-65 years) with relapsing-remitting MS or clinically isolated syndrome and <10 year disease duration were selected from a longitudinal clinical study. Cross-sectional and longitudinal models assessed the relationship between two adipokines (leptin and FABP4) and disease severity in women and men, adjusting for age, disease duration and disease type, Vitamin D level, testosterone level, and as well by body mass index (BMI).Mean age of subjects ( N = 163, 56% women) was 39.3 years. Higher FABP4 levels were associated with higher Expanded Disability Status Scale (EDSS) scores in women in both univariate and multivariate analyses (odds ratio: 1.30; p = 0.005). In men, higher FABP4 level was significantly associated with change in EDSS over time (estimate: 0.0062; p = 0.035). We found no association of FABP4 levels with time to next relapse or a measure of processing speed.RESULTSMean age of subjects ( N = 163, 56% women) was 39.3 years. Higher FABP4 levels were associated with higher Expanded Disability Status Scale (EDSS) scores in women in both univariate and multivariate analyses (odds ratio: 1.30; p = 0.005). In men, higher FABP4 level was significantly associated with change in EDSS over time (estimate: 0.0062; p = 0.035). We found no association of FABP4 levels with time to next relapse or a measure of processing speed.FABP4 levels may be associated with increased disability in both men and women with MS independent of effects of BMI and other hormones. Future studies should expand these analyses and further explore downstream mechanisms of adiposity-related effects in MS.CONCLUSIONFABP4 levels may be associated with increased disability in both men and women with MS independent of effects of BMI and other hormones. Future studies should expand these analyses and further explore downstream mechanisms of adiposity-related effects in MS. |
| Author | Kivisäkk, Pia Sattarnezhad, Neda Soltany, Pejvak Miller, Karen K Chitnis, Tanuja Glanz, Bonnie I Diaz-Cruz, Camilo Bove, Riley Musallam, Alexander Healy, Brain C |
| Author_xml | – sequence: 1 givenname: Riley surname: Bove fullname: Bove, Riley organization: Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA/Harvard Medical School, Boston, MA, USA/ Ann Romney Center for Neurologic Disease, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA – sequence: 2 givenname: Brain C surname: Healy fullname: Healy, Brain C organization: Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA/Harvard Medical School, Boston, MA, USA/Ann Romney Center for Neurologic Disease, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA/Massachusetts General Hospital's Biostatistics Center, Boston, MA, USA – sequence: 3 givenname: Alexander surname: Musallam fullname: Musallam, Alexander organization: Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA – sequence: 4 givenname: Pejvak surname: Soltany fullname: Soltany, Pejvak organization: Ann Romney Center for Neurologic Disease, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA – sequence: 5 givenname: Camilo surname: Diaz-Cruz fullname: Diaz-Cruz, Camilo organization: Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA – sequence: 6 givenname: Neda surname: Sattarnezhad fullname: Sattarnezhad, Neda organization: Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA – sequence: 7 givenname: Bonnie I surname: Glanz fullname: Glanz, Bonnie I organization: Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA/Harvard Medical School, Boston, MA, USA/ Ann Romney Center for Neurologic Disease, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA – sequence: 8 givenname: Pia surname: Kivisäkk fullname: Kivisäkk, Pia organization: Harvard Medical School, Boston, MA, USA/Ann Romney Center for Neurologic Disease, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA – sequence: 9 givenname: Karen K surname: Miller fullname: Miller, Karen K organization: Harvard Medical School, Boston, MA, USA/Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA, USA – sequence: 10 givenname: Tanuja surname: Chitnis fullname: Chitnis, Tanuja organization: Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA/Harvard Medical School, Boston, MA, USA/ Ann Romney Center for Neurologic Disease, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29320952$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkE1LxDAYhIOsuB969yQ5eqkmadKkR1lcFRa86MFTeZuk-kqb1iZF9t9bcAVPM4d5hmHWZBH64Am55OyGc61vea6EVEbNXjFdmBOy4lLrjJWaLf75JVnH-MkY0zpXZ2QpylywUokVedtBSgcKFh2tMTgM73QY--QxZJJipBBjbxGSd_Qb0wd1GKHGFmcIA-2mNuHQehpt68c-zsAACX1I8ZycNtBGf3HUDXnd3b9sH7P988PT9m6fWSlYyoA56WqRMyNzB4Vz3EvTMF2LwlvBhDISag62BlBWNIqbUpicl7xpuJo5sSHXv73z7K_Jx1R1GK1vWwi-n2LFS1MqrWXO5ujVMTrVnXfVMGIH46H6u0P8AIVYZCk |
| CitedBy_id | crossref_primary_10_1186_s12974_022_02502_1 crossref_primary_10_3389_fimmu_2022_1038393 crossref_primary_10_1016_j_neubiorev_2023_105035 crossref_primary_10_1080_14740338_2020_1807002 crossref_primary_10_1093_advances_nmac065 crossref_primary_10_1007_s13365_022_01094_z crossref_primary_10_1038_s41467_025_60747_9 crossref_primary_10_1159_000543940 crossref_primary_10_1016_j_molmet_2023_101783 crossref_primary_10_1016_j_ebiom_2021_103603 crossref_primary_10_2217_pme_2022_0016 crossref_primary_10_1016_j_humimm_2025_111269 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1177/1352458517750768 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1477-0970 |
| ExternalDocumentID | 29320952 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: K24 HL092902 – fundername: NCATS NIH HHS grantid: UL1 TR000170 – fundername: NICHD NIH HHS grantid: K12 HD051959 – fundername: NIA NIH HHS grantid: L30 AG048592 |
| GroupedDBID | --- -TM .2E .2F .2G .2J .2N 01A 0R~ 123 18M 1~K 29M 31R 31S 31U 31X 31Y 31Z 36B 39C 4.4 53G 54M 5VS 7X7 88E 8FI 8FJ 8R4 8R5 AABMB AABOD AACKU AACMV AACTG AADUE AAEWN AAGGD AAGMC AAJIQ AAJOX AAJPV AAKGS AANSI AAPEO AAQDB AAQXH AAQXI AARDL AARIX AATAA AATBZ AAUAS AAXOT AAYTG AAZBJ ABAFQ ABAWC ABAWP ABCCA ABCJG ABDWY ABEIX ABFWQ ABHFT ABHKI ABHQH ABJIS ABJNI ABKRH ABLUO ABNCE ABPGX ABPNF ABQKF ABQXT ABRHV ABUJY ABUWG ABVFX ABVVC ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACFYK ACGBL ACGFO ACGFS ACGZU ACJER ACJTF ACLFY ACLHI ACLZU ACNXM ACOFE ACOXC ACPRK ACROE ACRPL ACSIQ ACUAV ACUIR ACXKE ACXMB ADBBV ADDLC ADEIA ADMPF ADNBR ADNMO ADNON ADRRZ ADTBJ ADUCT ADUKL ADVBO ADYCS ADZYD ADZZY AECGH AECVZ AEDTQ AEKYL AENEX AEPTA AEQLS AERKM AESZF AEUHG AEWDL AEWHI AEXFG AEXNY AFEET AFKBI AFKRA AFKRG AFMOU AFQAA AFUIA AFVCE AFWMB AGHKR AGKLV AGNHF AGPXR AGWFA AGWNL AHDMH AHHFK AHMBA AIGRN AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ AJXGE ALIPV ALKWR ALMA_UNASSIGNED_HOLDINGS ALTZF AMCVQ ANDLU ARTOV ASPBG AUTPY AVWKF AYAKG AZFZN AZQEC B3H B8M B8O B8R B8Z B93 B94 BBRGL BDDNI BENPR BKIIM BKNYI BKSCU BPACV BPHCQ BSEHC BVXVI BWJAD BYIEH CAG CBRKF CCPQU CDWPY CFDXU CGR COF CORYS CQQTX CS3 CUTAK CUY CVF DB0 DC- DC0 DD- DD0 DE- DF0 DO- DOPDO DU5 DV7 DV9 D~Y EBS ECM EIF EJD EMOBN F5P FD6 FEDTE FHBDP FYUFA GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HMCUK HVGLF HZ~ J8X K.F K.J K9- M0R M1P M4V N9A NPM O9- P.B P2P PHGZT PQQKQ PROAC PSQYO Q1R Q2X Q7K Q7L Q7R Q7U Q7X Q82 Q83 ROL S01 SAUOL SCNPE SDB SFB SFC SFK SFN SFT SGA SGO SGP SGR SGV SGX SGZ SHG SNB SPJ SPQ SPV SQCSI STM UKHRP XJT ZONMY ZPPRI ZRKOI ZSSAH 7X8 AAPII ABIDT ABJZC ADEBD AJGYC AJHME AJVBE SASJQ |
| ID | FETCH-LOGICAL-c420t-a0d4db230843da6dd1e48f07b26ec202584ab1acbaa5c2f5189283191ff15b232 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 14 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000460691800009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1477-0970 |
| IngestDate | Sun Sep 28 10:00:58 EDT 2025 Thu Apr 03 07:08:38 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | fatty acid binding protein Body mass index gender leptin multiple sclerosis |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c420t-a0d4db230843da6dd1e48f07b26ec202584ab1acbaa5c2f5189283191ff15b232 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 29320952 |
| PQID | 1989577430 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1989577430 pubmed_primary_29320952 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-03-01 |
| PublicationDateYYYYMMDD | 2019-03-01 |
| PublicationDate_xml | – month: 03 year: 2019 text: 2019-03-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Multiple sclerosis |
| PublicationTitleAlternate | Mult Scler |
| PublicationYear | 2019 |
| SSID | ssj0007735 |
| Score | 2.3288887 |
| Snippet | Increased adiposity is a risk factor for multiple sclerosis (MS) and is associated with increased disability scores. Adipokines may mediate the effects of... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 344 |
| SubjectTerms | Adiposity Adult Body Mass Index Disabled Persons Fatty Acid-Binding Proteins - blood Female Humans Leptin - blood Longitudinal Studies Male Middle Aged Multiple Sclerosis, Relapsing-Remitting - blood Multiple Sclerosis, Relapsing-Remitting - physiopathology Severity of Illness Index Sex Factors |
| Title | Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29320952 https://www.proquest.com/docview/1989577430 |
| Volume | 25 |
| WOSCitedRecordID | wos000460691800009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7qinjx_VhfRPAaNsmmSXoSERcvu-xBYT2VNA_opbvaKvjvnXSz7EkQvPQ2pUynmW_mm36D0J20IuQuBEJDbohwQ0ZyF1X3vc2405xJbrtlE2oy0bNZPk0NtyaNVa7OxO6gdnMbe-SDONuTAVYZ0vvFO4lboyK7mlZobKLeEKBMjGo1W6uFK9Ut2GRCKUJzRdc05YAB8BCRElOQMpXUvwPMLtGM9v_7iAdoL0FM_LCMiUO04esjtDNOJPoxehuZtv3GxlYOl1X3Vwvu5BqqmghcNdikV-Ydjm1a7JIOLxhVNV6NIOIG7g45FgySOGtzgl5HTy-PzyRtWCBWcNoSQ51wJVQhWgydkc4xL3SgquTSWw5wSAtTMmNLYzLLQ8Z0DnAESrwQWAZ2_BRt1fPanyNsNGAZKksjY9EVQm49szYT0nMqnc766HbltAIiONISpvbzz6ZYu62PzpaeLxZLqY0CwAgHEMgv_mB9iXYBzeTLAbEr1Avw_fprtG2_2qr5uOlCA66T6fgHDw_DdA |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fatty+acid+binding+protein-4+is+associated+with+disability+in+multiple+sclerosis+patients&rft.jtitle=Multiple+sclerosis&rft.au=Bove%2C+Riley&rft.au=Healy%2C+Brain+C&rft.au=Musallam%2C+Alexander&rft.au=Soltany%2C+Pejvak&rft.date=2019-03-01&rft.eissn=1477-0970&rft.volume=25&rft.issue=3&rft.spage=344&rft_id=info:doi/10.1177%2F1352458517750768&rft_id=info%3Apmid%2F29320952&rft_id=info%3Apmid%2F29320952&rft.externalDocID=29320952 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-0970&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-0970&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-0970&client=summon |